XML 86 R72.htm IDEA: XBRL DOCUMENT v3.25.1
Earnings Per Common Share and Summary of Share-Based Award Transactions (Details) - SARs - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, SARS, Outstanding [Roll Forward]      
Number Of Shares, Outstanding Beginning Balance 42 39  
Number Of Shares, SARs granted 5 5  
Number Of Shares, SARs exercised (19) (2)  
Number Of Shares, Outstanding Ending Balance 28 42 39
Number Of Shares, Exercisable as of December 31, 2024 22    
Number Of Shares, Unvested as of December 31, 2024 6    
Share-based Compensation Arrangement by Share-based Payment Award, SARS, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Weighted Average Exercise Price, Outstanding Beginning Balance $ 160.83 $ 159.39  
Weighted Average Exercise Price, SARs granted 160.94 142.88  
Weighted Average Exercise Price, SARs exercised 170.21 93.87  
Weighted Average Exercise Price, Outstanding Ending Balance 154.71 $ 160.83 $ 159.39
Weighted Average Exercise Price, Exercisable as of December 31, 2024 156.73    
Weighted Average Exercise Price, Unvested as of December 31, 2024 $ 146.79    
Average Remaining Contractual Term, Outstanding Beginning Balance 3 years 10 months 24 days 3 years 8 months 8 days 4 years 1 month 6 days
Average Remaining Contractual Term, Exercisable as of December 31, 2024 3 years 9 months 10 days    
Average Remaining Contractual Term, Unvested as of December 31, 2024 4 years 4 months 24 days    
Aggregate Intrinsic Value, Outstanding Beginning Balance $ 428 $ 243  
Aggregate Intrinsic Value, Outstanding Ending Balance 2,312 $ 428 $ 243
Aggregate Intrinsic Value, Exercisable as of December 31, 2024 1,797    
Aggregate Intrinsic Value, Unvested as of December 31, 2024 $ 515